HFn-DOX could accumulate in the tumor site exploiting the EPR effect [42] or by endothelial wall transcytosis promoted by TfR-1 recognition [43] and it is internalized in tumor cells by receptor-mediated endocytosis [44]. This evidence concerns the gene TFRC and neoplasm.